Correlation Between Protagonist Therapeutics and Immunovant
Can any of the company-specific risk be diversified away by investing in both Protagonist Therapeutics and Immunovant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagonist Therapeutics and Immunovant into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagonist Therapeutics and Immunovant, you can compare the effects of market volatilities on Protagonist Therapeutics and Immunovant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagonist Therapeutics with a short position of Immunovant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagonist Therapeutics and Immunovant.
Diversification Opportunities for Protagonist Therapeutics and Immunovant
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Protagonist and Immunovant is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Protagonist Therapeutics and Immunovant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunovant and Protagonist Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagonist Therapeutics are associated (or correlated) with Immunovant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunovant has no effect on the direction of Protagonist Therapeutics i.e., Protagonist Therapeutics and Immunovant go up and down completely randomly.
Pair Corralation between Protagonist Therapeutics and Immunovant
Given the investment horizon of 90 days Protagonist Therapeutics is expected to generate 1.22 times less return on investment than Immunovant. But when comparing it to its historical volatility, Protagonist Therapeutics is 1.34 times less risky than Immunovant. It trades about 0.16 of its potential returns per unit of risk. Immunovant is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 2,851 in Immunovant on July 30, 2024 and sell it today you would earn a total of 171.00 from holding Immunovant or generate 6.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Protagonist Therapeutics vs. Immunovant
Performance |
Timeline |
Protagonist Therapeutics |
Immunovant |
Protagonist Therapeutics and Immunovant Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Protagonist Therapeutics and Immunovant
The main advantage of trading using opposite Protagonist Therapeutics and Immunovant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagonist Therapeutics position performs unexpectedly, Immunovant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunovant will offset losses from the drop in Immunovant's long position.Protagonist Therapeutics vs. Revolution Medicines | Protagonist Therapeutics vs. Akero Therapeutics | Protagonist Therapeutics vs. Avidity Biosciences | Protagonist Therapeutics vs. Stoke Therapeutics |
Immunovant vs. Arbutus Biopharma Corp | Immunovant vs. Arcutis Biotherapeutics | Immunovant vs. Legend Biotech Corp | Immunovant vs. Protagonist Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |